Supplement Shoppers Aren't Cheap. They're Unconvinced.

Ask the supplement industry why conversion is hard and you'll hear about price sensitivity. Ask 230 shoppers and you'll hear something else. On Echo's cost-sensitivity spectrum, only 6% of respondents treat price as the primary deciding factor. 58% lean the other way: willing to pay a premium for proven health benefit.

The category doesn't have a price problem. It has a proof problem, and the proof problem is severe.

Nobody Believes You

Asked directly how much they trust health supplement claims, the sample scored a 2.8 out of 5. Just 18.3% land at 4 or 5. More than twice as many, 37.4%, actively distrust the claims, and the rest sit in the skeptical middle.

The brand-level numbers are more brutal. Across five challenger supplement brands tested, 63.5% of respondents had used none of them in the past twelve months, and 57.1% said they trust none of them most. The best performer, Garden of Life, earned the trust of 19%. A lifestyle performance brand in the set, with real cultural presence in fitness circles, was recognized by 12% and trusted most by 5.3%.

In this category, the default setting is not brand-agnostic. It is brand-averse.

What Shoppers Say Would Convince Them

The choice drivers are unambiguous. Ingredient transparency dominates at 58.3%, with price a distant second and brand reputation nearly irrelevant.

Which factor matters most when choosing a supplement?

• Ingredient transparency58.3%
• Price23%
• Brand reputation10%
• Something else8.7%

Ranked attributes tell the same story: safety (avg rank 1.6) and effectiveness (1.7) tower over convenience (3.2) and taste (3.5). And when asked in their own words what would make a supplement essential, 44% pointed to a concrete health need or benefit, and another 18% to safety and efficacy evidence. Marketing-flavored answers barely register.

The cost-sensitivity spectrum

cost-consciouspays for proof →

36%

58%

• Price-first6%
• Mixed36%
• Premium for proven benefit58%

Put the spectrum next to the trust numbers and the category's real shape appears. A majority will pay more, today, for a product that proves its benefit. Almost nobody currently believes the proof on offer. The money is sitting behind the proof wall, and brands keep discounting instead of drilling.

Four Audiences, One Common Demand

Echo's archetype model split the sample four ways, and the segments disagree about nearly everything except evidence.

Supplement audience archetypes

• Performance-Focused Premium Loyalists45%
• Cost-Focused, Doctor-Validated Seekers29%
• Deficiency-Driven Brand-Averse16%
• Premium Transparency Seekers10%

The Performance Loyalists, the largest group at 45%, already pay premiums and stay loyal once a product demonstrably works. The Doctor-Validated Seekers need professional endorsement before spending. The Brand-Averse buy against lab results and diagnosed gaps, not marketing. The Transparency Seekers read labels like research papers. Different triggers, one common demand: show, don't claim. Even the endorsement question splits on evidence, with 51% saying personal experience of benefit is sufficient proof versus 17% who require an expert's word.

What This Means

• Lead with transparency, not lifestyle. 58.3% choose on ingredient openness; 10% choose on brand reputation.
• Price is a scapegoat. Prove the benefit and the majority of the category self-reports premium willingness.
• Match the proof to the segment: lab results for the brand-averse, clinician voice for the doctor-validated, visible performance outcomes for the loyalists.
• Immune support (65.2%) and energy (57.4%) are the benefit language the market already speaks. Prove those first.

Interest is free. Proof gets paid.

Study: supplement category test, n=230, US respondents, June 2026, subject brand anonymized.